Cizutamig is a tetravalent bispecific antibody targeting BCMA and CD3. Cizutamig exhibits potential immunostimulatory and antineoplastic activities[1].
Molecular Weight:
(241.429 kDa)
Purity:
95
CAS Number:
[2919209-65-5]
Target:
CD3
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted